Clinical Trials Logo

Clinical Trial Summary

To explore the efficacy and safety of "Manpixiao" in the treatment of Chronic Atrophic Gastritis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05493124
Study type Interventional
Source Beijing University of Chinese Medicine
Contact
Status Recruiting
Phase Early Phase 1
Start date July 1, 2021
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06085677 - The Gastric HormonE BioMarkers of Preneoplastic Lesions Study
Completed NCT02955134 - The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis N/A
Active, not recruiting NCT05808010 - Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis N/A
Terminated NCT01444014 - YF476 and Type I Gastric Carcinoids (Norway) Phase 2
Completed NCT01339169 - YF476 and Type I Gastric Carcinoids Phase 2
Active, not recruiting NCT06267703 - Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions
Recruiting NCT03597672 - Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)
Recruiting NCT05388890 - Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation
Active, not recruiting NCT02782949 - Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Phase 2